Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Enflurane | hsa00053 | Ascorbate and aldarate metabolism | 5.61E-03 | 2 | P51648, Q9UEF7 | ALDH3A2, KL | More | | Enflurane | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Enflurane | hsa00190 | Oxidative phosphorylation | 3.50E-02 | 2 | Q16718, Q13488 | NDUFA5, TCIRG1 | More | | Enflurane | hsa00280 | Valine, leucine and isoleucine degradation | 4.55E-02 | 2 | P21953, P51648 | BCKDHB, ALDH3A2 | More | | Enflurane | hsa00310 | Lysine degradation | 1.53E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Enflurane | hsa00380 | Tryptophan metabolism | 4.14E-02 | 1 | Q16613 | AANAT | More | | Enflurane | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 4.32E-02 | 1 | Q9Y2C2 | UST | More | | Enflurane | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Enflurane | hsa00600 | Sphingolipid metabolism | 3.01E-02 | 2 | Q9BX95, P06280 | SGPP1, GLA | More | | Enflurane | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 1.34E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Enflurane | hsa00620 | Pyruvate metabolism | 4.20E-02 | 2 | P40926, P14550 | MDH2, AKR1A1 | More | | Enflurane | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.09E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Enflurane | hsa01100 | Metabolic pathways | 4.56E-02 | 11 | P15144, P32320, P06280, P24666, P33121, P42330, Q13093, Q9NY28, Q9BX95, P09960, Q16718 | ANPEP, CDA, GLA, ACP1, ACSL1, AKR1C3, PLA2G7, GALNT8, SGPP1, LTA4H, NDUFA5 | More | | Enflurane | hsa03008 | Ribosome biogenesis in eukaryotes | 4.94E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Enflurane | hsa03010 | Ribosome | 4.88E-09 | 16 | P62753, P42677, P32969, P40429, P62917, P46776, P46777, Q9H0U6, Q07020, P62910, Q02878, P36578, P50914, P05386, P62249, P23396 | RPS6, RPS27, RPL9, RPL13A, RPL8, RPL27A, RPL5, MRPL18, RPL18, RPL32, RPL6, RPL4, RPL14, RPLP1, RPS16, RPS3 | More | | Enflurane | hsa03020 | RNA polymerase | 9.86E-07 | 2 | Q9GZM3, P52435 | POLR2J2, POLR2J | More | | Enflurane | hsa03040 | Spliceosome | 3.94E-04 | 8 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q01130, O43447 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS2, PPIH | More | | Enflurane | hsa03050 | Proteasome | 1.40E-02 | 1 | P55036 | PSMD4 | More | | Enflurane | hsa04014 | Ras signaling pathway | 3.62E-02 | 5 | P42338, P49767, P0DP23, P63218, P50151 | PIK3CB, VEGFC, CALM1, GNG5, GNG10 | More | | Enflurane | hsa04020 | Calcium signaling pathway | 5.15E-05 | 8 | P27987, P21796, Q16566, P30679, O15399, P0DP23, P23634, P49767 | ITPKB, VDAC1, CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Enflurane | hsa04024 | cAMP signaling pathway | 6.68E-05 | 12 | P49019, P63092, P22694, P42338, P26678, P0DP23, P20020, P23634, P61586, Q16566, P48058, O15399 | HCAR3, GNAS, PRKACB, PIK3CB, PLN, CALM1, ATP2B1, ATP2B4, RHOA, CAMK4, GRIA4, GRIN2D | More | | Enflurane | hsa04070 | Phosphatidylinositol signaling system | 1.49E-03 | 5 | P0DP23, P42338, Q96PE3, Q13572, P27987 | CALM1, PIK3CB, INPP4A, ITPK1, ITPKB | More | | Enflurane | hsa04072 | Phospholipase D signaling pathway | 2.75E-02 | 3 | P61586, O14986, P63092 | RHOA, PIP5K1B, GNAS | More | | Enflurane | hsa04120 | Ubiquitin mediated proteolysis | 6.89E-03 | 5 | Q14145, Q13042, Q13191, Q15751, Q7Z6Z7 | KEAP1, CDC16, CBLB, HERC1, HUWE1 | More | | Enflurane | hsa04137 | Mitophagy - animal | 2.52E-02 | 2 | P19784, P67870 | CSNK2A2, CSNK2B | More | | Enflurane | hsa04141 | Protein processing in endoplasmic reticulum | 9.57E-03 | 4 | P30101, P49257, P60604, Q9H173 | PDIA3, LMAN1, UBE2G2, SIL1 | More | | Enflurane | hsa04145 | Phagosome | 2.75E-02 | 4 | Q15080, P14598, P68371, Q13488 | NCF4, NCF1, TUBB2C, TCIRG1 | More | | Enflurane | hsa04150 | mTOR signaling pathway | 7.19E-03 | 3 | Q9NQL2, Q13322, Q93098 | RRAGD, GRB10, WNT8B | More | | Enflurane | hsa04217 | Necroptosis | 1.70E-02 | 5 | P01568, Q13489, P08238, O43633, Q08752 | IFNA21, BIRC3, HSP90AB1, CHMP2A, PPID | More | | Enflurane | hsa04310 | Wnt signaling pathway | 4.17E-03 | 3 | P61586, P19784, P67870 | RHOA, CSNK2A2, CSNK2B | More | | Enflurane | hsa04371 | Apelin signaling pathway | 7.45E-03 | 5 | P63218, P50151, Q13485, Q16566, P0DP23 | GNG5, GNG10, SMAD4, CAMK4, CALM1 | More | | Enflurane | hsa04510 | Focal adhesion | 4.07E-02 | 3 | O14986, P61586, Q16363 | PIP5K1B, RHOA, LAMA4 | More | | Enflurane | hsa04520 | Adherens junction | 1.38E-04 | 3 | P19784, P67870, P61586 | CSNK2A2, CSNK2B, RHOA | More | | Enflurane | hsa04610 | Complement and coagulation cascades | 4.69E-03 | 1 | P0C0L4 | C4A | More | | Enflurane | hsa04621 | NOD-like receptor signaling pathway | 4.31E-02 | 4 | P01375, P59665, P59666, P12838 | TNF, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Enflurane | hsa04650 | Natural killer cell mediated cytotoxicity | 2.11E-02 | 4 | P17252, O60880, P26717, P26715 | PRKCA, SH2D1A, KLRC2, KLRC1 | More | | Enflurane | hsa04664 | Fc epsilon RI signaling pathway | 2.32E-02 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Enflurane | hsa04666 | Fc gamma R-mediated phagocytosis | 4.10E-02 | 3 | P07948, P42338, P23528 | LYN, PIK3CB, CFL1 | More | | Enflurane | hsa04713 | Circadian entrainment | 4.54E-05 | 9 | O15399, P0DP23, P17252, P62873, P63218, P50151, P48058, P22694, P63092 | GRIN2D, CALM1, PRKCA, GNB1, GNG5, GNG10, GRIA4, PRKACB, GNAS | More | | Enflurane | hsa04714 | Thermogenesis | 3.16E-02 | 3 | P22694, P33121, Q16718 | PRKACB, ACSL1, NDUFA5 | More | | Enflurane | hsa04720 | Long-term potentiation | 1.63E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Enflurane | hsa04721 | Synaptic vesicle cycle | 1.14E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Enflurane | hsa04723 | Retrograde endocannabinoid signaling | 1.47E-04 | 6 | P17252, P48169, P62873, P48058, P22694, Q16718 | PRKCA, GABRA4, GNB1, GRIA4, PRKACB, NDUFA5 | More | | Enflurane | hsa04724 | Glutamatergic synapse | 1.40E-04 | 8 | P48058, O15399, P63092, P22694, P17252, P62873, P63218, P50151 | GRIA4, GRIN2D, GNAS, PRKACB, PRKCA, GNB1, GNG5, GNG10 | More | | Enflurane | hsa04725 | Cholinergic synapse | 5.94E-03 | 4 | P63218, P50151, Q16566, P42338 | GNG5, GNG10, CAMK4, PIK3CB | More | | Enflurane | hsa04726 | Serotonergic synapse | 7.85E-05 | 9 | P63092, P22694, P17252, P31645, P62873, P63218, P50151, P33260, P09917 | GNAS, PRKACB, PRKCA, SLC6A4, GNB1, GNG5, GNG10, CYP2C18, ALOX5 | More | | Enflurane | hsa04727 | GABAergic synapse | 4.55E-02 | 2 | P50151, P15104 | GNG10, GLUL | More | | Enflurane | hsa04728 | Dopaminergic synapse | 4.47E-02 | 4 | P63218, P50151, P0DP23, O00327 | GNG5, GNG10, CALM1, ARNTL | More | | Enflurane | hsa04911 | Insulin secretion | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Enflurane | hsa04913 | Ovarian steroidogenesis | 1.28E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Enflurane | hsa04918 | Thyroid hormone synthesis | 3.01E-02 | 2 | P22694, P17252 | PRKACB, PRKCA | More | | Enflurane | hsa04925 | Aldosterone synthesis and secretion | 8.50E-04 | 6 | P0DP23, P17252, Q16566, P22694, P20020, P23634 | CALM1, PRKCA, CAMK4, PRKACB, ATP2B1, ATP2B4 | More | | Enflurane | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P30679 | PIK3CB, GNG5, GNG10, VEGFC, GNA15 | More | | Enflurane | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Enflurane | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 9.85E-05 | 3 | P20020, P17252, P22694 | ATP2B1, PRKCA, PRKACB | More | | Enflurane | hsa04962 | Vasopressin-regulated water reabsorption | 6.61E-03 | 2 | P22694, Q13561 | PRKACB, DCTN2 | More | | Enflurane | hsa04970 | Salivary secretion | 7.14E-03 | 3 | P22694, P20020, P17252 | PRKACB, ATP2B1, PRKCA | More | | Enflurane | hsa04972 | Pancreatic secretion | 1.29E-04 | 4 | P20020, P17252, P63092, P61586 | ATP2B1, PRKCA, GNAS, RHOA | More | | Enflurane | hsa04976 | Bile secretion | 3.01E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Enflurane | hsa05010 | Alzheimer disease | 7.11E-03 | 9 | O15239, P13073, P18848, O15169, P67870, P05141, P12236, P28070, P43686 | NDUFA1, COX4I1, ATF4, AXIN1, CSNK2B, SLC25A5, SLC25A6, PSMB4, PSMC4 | More | | Enflurane | hsa05012 | Parkinson disease | 2.14E-02 | 7 | O15239, P13073, P05141, P12236, P18848, P28070, P43686 | NDUFA1, COX4I1, SLC25A5, SLC25A6, ATF4, PSMB4, PSMC4 | More | | Enflurane | hsa05016 | Huntington disease | 2.46E-05 | 3 | Q9GZM3, P52435, Q9NYC9 | POLR2J2, POLR2J, DNAH9 | More | | Enflurane | hsa05017 | Spinocerebellar ataxia | 8.69E-04 | 8 | Q8TB72, O15399, P42338, P28070, P43686, P05141, P12236, P21796 | PUM2, GRIN2D, PIK3CB, PSMB4, PSMC4, SLC25A5, SLC25A6, VDAC1 | More | | Enflurane | hsa05020 | Prion disease | 1.55E-03 | 10 | P46531, O15239, P13073, P18848, P05141, P12236, P28070, P43686, P67870, P51636 | NOTCH1, NDUFA1, COX4I1, ATF4, SLC25A5, SLC25A6, PSMB4, PSMC4, CSNK2B, CAV2 | More | | Enflurane | hsa05022 | Pathways of neurodegeneration - multiple diseases | 5.20E-04 | 15 | P67870, O15239, Q16718, P13073, P18848, Q13561, P48058, P05141, P12236, P17252, P20333, O15169, Q08752, P28070, P43686 | CSNK2B, NDUFA1, NDUFA5, COX4I1, ATF4, DCTN2, GRIA4, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, PPID, PSMB4, PSMC4 | More | | Enflurane | hsa05031 | Amphetamine addiction | 1.69E-02 | 3 | P48058, P22694, P17252 | GRIA4, PRKACB, PRKCA | More | | Enflurane | hsa05032 | Morphine addiction | 9.04E-05 | 5 | P62873, P48169, P78334, P63092, P32298 | GNB1, GABRA4, GABRE, GNAS, GRK4 | More | | Enflurane | hsa05034 | Alcoholism | 3.62E-02 | 5 | O15399, Q16566, P0DP23, P63218, P50151 | GRIN2D, CAMK4, CALM1, GNG5, GNG10 | More | | Enflurane | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Enflurane | hsa05110 | Vibrio cholerae infection | 3.01E-02 | 2 | P17252, P22694 | PRKCA, PRKACB | More | | Enflurane | hsa05142 | Chagas disease | 2.26E-02 | 3 | P01375, P30679, P48023 | TNF, GNA15, FASLG | More | | Enflurane | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Enflurane | hsa05150 | Staphylococcus aureus infection | 1.61E-03 | 5 | P0C0L4, P13646, P59665, P59666, P12838 | C4A, KRT13, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Enflurane | hsa05163 | Human cytomegalovirus infection | 3.23E-03 | 9 | P42338, P62873, P63218, P50151, P0DP23, P61586, P63092, P30101, P61769 | PIK3CB, GNB1, GNG5, GNG10, CALM1, RHOA, GNAS, PDIA3, B2M | More | | Enflurane | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P07948, P0DP23 | PIK3CB, GNG5, GNG10, LYN, CALM1 | More | | Enflurane | hsa05170 | Human immunodeficiency virus 1 infection | 3.27E-02 | 6 | P42338, P63218, P50151, P0DP23, P30101, P23528 | PIK3CB, GNG5, GNG10, CALM1, PDIA3, CFL1 | More | | Enflurane | hsa05171 | Coronavirus disease - COVID-19 | 6.74E-07 | 15 | P23396, P62753, P62249, P42677, P40429, Q9UHA3, P36578, Q02878, P62917, P32969, Q07020, P46776, P62910, P05386, O14786 | RPS3, RPS6, RPS16, RPS27, RPL13A, RSL24D1, RPL4, RPL6, RPL8, RPL9, RPL18, RPL27A, RPL32, RPLP1, NRP1 | More | | Enflurane | hsa05204 | Chemical carcinogenesis | 4.62E-02 | 2 | P78417, P33260 | GSTO1, CYP2C18 | More | | Enflurane | hsa05214 | Glioma | 2.09E-03 | 5 | P09619, P0DP23, Q16566, Q02750, P42338 | PDGFRB, CALM1, CAMK4, MAP2K1, PIK3CB | More | | Enflurane | hsa05218 | Melanoma | 1.34E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Enflurane | hsa05224 | Breast cancer | 3.88E-02 | 3 | P46531, Q9UM47, O15169 | NOTCH1, NOTCH3, AXIN1 | More | | Enflurane | hsa05230 | Central carbon metabolism in cancer | 4.10E-02 | 2 | P09619, Q02750 | PDGFRB, MAP2K1 | More | | Enflurane | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Enflurane | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Enflurane | hsa05415 | Diabetic cardiomyopathy | 2.75E-02 | 4 | P17252, P14598, Q15080, Q16718 | PRKCA, NCF1, NCF4, NDUFA5 | More | | |